Evidence map›Paper›PMID 34503061›Full record

ArticleCancers2021

Deterioration of Intended Target Volume Radiation Dose Due to Anatomical Changes in Patients with Head-and-Neck Cancer.

Olga Hamming-Vrieze, Simon van Kranen, Iris Walraven, Arash Navran, Abrahim Al-Mamgani, Margot Tesselaar, Michiel van den Brekel, Jan-Jakob Sonke

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Olga Hamming-VriezeDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Simon van KranenDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Iris WalravenDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Arash NavranDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0001-7006-7807
Abrahim Al-MamganiDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Margot TesselaarDepartment of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Michiel van den BrekelDepartment of Head and Neck Surgery, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-6338-6743
Jan-Jakob SonkeDepartment of Radiation Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
The Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delivered radiation dose can differ from intended dose. This study quantifies dose deterioration in targets, identifies predictive factors, and compares dosimetric to clinical patient selection for adaptive radiotherapy in head-and-neck cancer patients. One hundred and eighty-eight consecutive head-and-neck cancer patients treated up to 70 Gy were analyzed. Daily delivered dose was calculated, accumulated, and compared to the planned dose. Cutoff values (1 Gy/2 Gy) were used to assess plan deterioration in the highest/lowest dose percentile (D

Indexed as

adaptive radiotherapycone beam CTdose accumulationhead-and-neck cancer

Identifiers

PMID34503061
PMCPMC8428222
OpenAlexW3193435647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.